Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012 (2012), Article ID 430490, 4 pages
http://dx.doi.org/10.1155/2012/430490
Case Report

Mycoplasma pneumoniae-Induced-Stevens Johnson Syndrome: Rare Occurrence in an Adult Patient

1Division of Infectious Diseases, Department of Internal Medicine, Howard University Hospital, 2041 Georgia Avenue NW, Washington, DC 20060, USA
2Department of Internal Medicine, Howard University Hospital, 2041 Georgia Avenue NW, Washington, DC 20060, USA
3Division of Pulmonary, Department of Internal Medicine, Howard University Hospital, 2041 Georgia Avenue NW, Washington, DC 20060, USA

Received 9 April 2012; Revised 2 July 2012; Accepted 22 July 2012

Academic Editor: Chin-Jung Wang

Copyright © 2012 Samad Rasul et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. C. Schalock and J. G. H. Dinulos, “Mycoplasma pneumoniae-induced cutaneous disease,” International Journal of Dermatology, vol. 48, no. 7, pp. 673–681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Kunimi, Y. Hirata, M. Aihara et al., “Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan,” Allergology International, vol. 60, pp. 525–532, 2011. View at Google Scholar
  3. D. A. Wetter and M. J. Camilleri, “Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic,” Mayo Clinic Proceedings, vol. 85, no. 2, pp. 131–138, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Walicka, M. Majsterek, A. Rakowska et al., “Mycoplasma pneumoniae-induced pneumonia with Stevens-Johnson syndrome of acute atypical course,” Polskie Archiwum Medycyny Wewnetrznej, vol. 118, no. 7-8, pp. 449–453, 2008. View at Google Scholar · View at Scopus
  5. V. Tsai and J. Oman, “Stevens-Johnson syndrome after Mycoplasma pneumoniae infection,” The Journal of Emergency Medicine, vol. 40, no. 3, pp. 324–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. D. Cherry, “Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections,” Clinical Infectious Diseases, vol. 17, supplement 1, pp. S47–S51, 1993. View at Google Scholar · View at Scopus
  7. M. R. Hammerschlag, “Mycoplasma pneumoniae infections,” Current Opinion in Infectious Diseases, vol. 14, no. 2, pp. 181–186, 2001. View at Google Scholar · View at Scopus
  8. M. A. Martínez, M. Ruiz, E. Zunino, V. Luchsinger, and L. F. Avendaño, “Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology,” Journal of Medical Microbiology, vol. 57, no. 12, pp. 1491–1495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Schneck, J. P. Fagot, P. Sekula, B. Sassolas, J. C. Roujeau, and M. Mockenhaupt, “Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study,” Journal of the American Academy of Dermatology, vol. 58, no. 1, pp. 33–40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. D. W. Metry, P. Jung, and M. L. Levy, “Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature,” Pediatrics, vol. 112, no. 6, pp. 1430–1436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Bachot, J. Revuz, and J. C. Roujeau, “Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression,” Archives of Dermatology, vol. 139, no. 1, pp. 33–36, 2003. View at Publisher · View at Google Scholar · View at Scopus